{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:46:12Z","timestamp":1792593972120,"version":"4.5.0"},"reference-count":194,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Saudi Pharm. J."],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s44446-025-00005-7","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:22:45Z","timestamp":1747995765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Cannabidiol as an immune modulator: A comprehensive review"],"prefix":"10.1007","volume":"33","author":[{"given":"Khizra","family":"Mujahid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shahzaib","family":"Rasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azka","family":"Sabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0397-1449","authenticated-orcid":false,"given":"Jutaek","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"Ramzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waseem","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1337-8574","authenticated-orcid":false,"given":"Imran","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1021\/ja01858a058","volume":"62","author":"R Adams","year":"1940","unstructured":"Adams R, Hunt M, Clark J (1940) Structure of cannabidiol, a product isolated from the marihuana extract of Minnesota wild hemp. I. J Am Chem Soc 62:196\u2013200","journal-title":"J Am Chem Soc"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1007\/bf02085029","volume":"37","author":"S Agurell","year":"1981","unstructured":"Agurell S, Carlsson S, Lindgren JE, Ohlsson A et al (1981) Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography. Experientia 37:1090\u20131092. https:\/\/doi.org\/10.1007\/bf02085029","journal-title":"Experientia"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1124\/dmd.112.047878","volume":"41","author":"A Al Saabi","year":"2013","unstructured":"Al Saabi A, Allorge D, Sauvage F-L, Tournel G et al (2013) Involvement of UDP-glucuronosyltransferases UGT1A9 and UGT2B7 in ethanol glucuronidation, and interactions with common drugs of abuse. Drug Metab Dispos 41:568\u2013574. https:\/\/doi.org\/10.1124\/dmd.112.047878","journal-title":"Drug Metab Dispos"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ceca.2015.02.001","volume":"57","author":"RM Ali","year":"2015","unstructured":"Ali RM, Al Kury LT, Yang K-HS, Qureshi A et al (2015) Effects of cannabidiol on contractions and calcium signaling in rat ventricular myocytes. Cell Calcium 57:290\u2013299. https:\/\/doi.org\/10.1016\/j.ceca.2015.02.001","journal-title":"Cell Calcium"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/ecco-jcc\/jjy185","volume":"13","author":"T Ambrose","year":"2019","unstructured":"Ambrose T, Simmons A (2019) Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease? J Crohns Colitis 13:525\u2013535. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy185","journal-title":"J Crohns Colitis"},{"key":"5_CR6","doi-asserted-by":"publisher","unstructured":"Andradas C, Truong A, Byrne J, Endersby R (2021) The role of cannabinoids as anticancer agents in pediatric oncology. Cancers (Basel) 13. https:\/\/doi.org\/10.3390\/cancers13010157","DOI":"10.3390\/cancers13010157"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1523\/jneurosci.23-07-02511.2003","volume":"23","author":"A Ar\u00e9valo-Mart\u00edn","year":"2003","unstructured":"Ar\u00e9valo-Mart\u00edn A, Vela JM, Molina-Holgado E, Borrell J et al (2003) Therapeutic action of cannabinoids in a murine model of multiple sclerosis. J Neurosci 23:2511\u20132516. https:\/\/doi.org\/10.1523\/jneurosci.23-07-02511.2003","journal-title":"J Neurosci"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3390\/ph17101382","volume":"17","author":"M Aswad","year":"2024","unstructured":"Aswad M, Pechkovsky A, Ghanayiem N, Hamza H et al (2024) High-CBD Extract (CBD-X) in Asthma Management: Reducing Th2-Driven Cytokine Secretion and Neutrophil\/Eosinophil Activity. Pharmaceuticals 17:1382. https:\/\/doi.org\/10.3390\/ph17101382","journal-title":"Pharmaceuticals"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/9442","volume":"5","author":"MA Atkinson","year":"1999","unstructured":"Atkinson MA, Leiter EH (1999) The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 5:601\u2013604. https:\/\/doi.org\/10.1038\/9442","journal-title":"Nat Med"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/cpdd.408","volume":"7","author":"J Atsmon","year":"2018","unstructured":"Atsmon J, Heffetz D, Deutsch L, Deutsch F et al (2018) Single-dose pharmacokinetics of oral cannabidiol following administration of PTL101: a new formulation based on gelatin matrix pellets technology. Clinical Pharmacology in Drug Development 7:751\u2013758. https:\/\/doi.org\/10.1002\/cpdd.408","journal-title":"Clinical Pharmacology in Drug Development"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1089\/can.2022.0133","volume":"8","author":"AI Aziz","year":"2023","unstructured":"Aziz AI, Nguyen LC, Oumeslakht L, Bensussan A et al (2023) Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations. Cannabis Cannabinoid Res 8:254\u2013269. https:\/\/doi.org\/10.1089\/can.2022.0133","journal-title":"Cannabis Cannabinoid Res"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1080\/17512433.2022.2148655","volume":"15","author":"K Bardhi","year":"2022","unstructured":"Bardhi K, Coates S, Watson CJW, Lazarus P (2022) Cannabinoids and drug metabolizing enzymes: potential for drug-drug interactions and implications for drug safety and efficacy. Expert Rev Clin Pharmacol 15:1443\u20131460. https:\/\/doi.org\/10.1080\/17512433.2022.2148655","journal-title":"Expert Rev Clin Pharmacol"},{"key":"5_CR13","first-page":"178","volume":"82","author":"LR Bartner","year":"2018","unstructured":"Bartner LR, McGrath S, Rao S, Hyatt LK et al (2018) Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs. Can J Vet Res 82:178\u2013183","journal-title":"Can J Vet Res"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"14280","DOI":"10.1038\/s41598-018-32651-4","volume":"8","author":"P Berman","year":"2018","unstructured":"Berman P, Futoran K, Lewitus GM, Mukha D et al (2018) A new ESI-LC\/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis. Sci Rep 8:14280. https:\/\/doi.org\/10.1038\/s41598-018-32651-4","journal-title":"Sci Rep"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/syn.1075","volume":"41","author":"F Berrendero","year":"2001","unstructured":"Berrendero F, S\u00e1nchez A, Cabranes A, Puerta C et al (2001) Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis. Synapse 41:195\u2013202. https:\/\/doi.org\/10.1002\/syn.1075","journal-title":"Synapse"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","volume":"134","author":"T Bisogno","year":"2001","unstructured":"Bisogno T, Hanu\u0161 L, De Petrocellis L, Tchilibon S et al (2001) Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 134:845\u2013852. https:\/\/doi.org\/10.1038\/sj.bjp.0704327","journal-title":"Br J Pharmacol"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2174\/1381612822666161214153108","volume":"23","author":"I Bjelobaba","year":"2017","unstructured":"Bjelobaba I, Savic D, Lavrnja I (2017) Multiple Sclerosis and Neuroinflammation: The Overview of Current and Prospective Therapies. Curr Pharm des 23:693\u2013730. https:\/\/doi.org\/10.2174\/1381612822666161214153108","journal-title":"Curr Pharm des"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.3390\/molecules27175644","volume":"27","author":"S Blando","year":"2022","unstructured":"Blando S, Raffaele I, Chiricosta L, Valeri A et al (2022) Cannabidiol promotes neuronal differentiation using Akt and Erk pathways triggered by Cb1 signaling. Molecules 27:5644. https:\/\/doi.org\/10.3390\/molecules27175644","journal-title":"Molecules"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00213-020-05712-8","volume":"238","author":"SC Britch","year":"2021","unstructured":"Britch SC, Babalonis S, Walsh SL (2021) Cannabidiol: pharmacology and therapeutic targets. Psychopharmacology 238:9\u201328. https:\/\/doi.org\/10.1007\/s00213-020-05712-8","journal-title":"Psychopharmacology"},{"key":"5_CR20","doi-asserted-by":"publisher","unstructured":"Brown JD, Winterstein AG (2019) Potential adverse drug events and drug-drug interactions with medical and consumer cannabidiol (CBD) use. J Clin Med 8.\u00a0https:\/\/doi.org\/10.3390\/jcm8070989","DOI":"10.3390\/jcm8070989"},{"key":"5_CR21","doi-asserted-by":"publisher","unstructured":"Busquets Garcia A, Soria-Gomez E, Bellocchio L, Marsicano G (2016) Cannabinoid receptor type-1: breaking the dogmas. F1000Res 5.\u00a0https:\/\/doi.org\/10.12688\/f1000research.8245.1","DOI":"10.12688\/f1000research.8245.1"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11481-015-9615-z","volume":"10","author":"GA Cabral","year":"2015","unstructured":"Cabral GA, Rogers TJ, Lichtman AH (2015) Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function. J Neuroimmune Pharmacol 10:193\u2013203. https:\/\/doi.org\/10.1007\/s11481-015-9615-z","journal-title":"J Neuroimmune Pharmacol"},{"key":"5_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.nbd.2005.03.002","volume":"20","author":"A Cabranes","year":"2005","unstructured":"Cabranes A, Venderova K, de Lago E, Fezza F et al (2005) Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and\/or vanilloid receptors in a rat model of multiple sclerosis. Neurobiol Dis 20:207\u2013217. https:\/\/doi.org\/10.1016\/j.nbd.2005.03.002","journal-title":"Neurobiol Dis"},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1021\/acs.jnatprod.3c00782","volume":"87","author":"D Cao","year":"2024","unstructured":"Cao D, Lin Y, Lin C, Xu M et al (2024) Cannabidiol Inhibits Epithelial Ovarian Cancer: Role of Gut Microbiome. J Nat Prod 87:1501\u20131512. https:\/\/doi.org\/10.1021\/acs.jnatprod.3c00782","journal-title":"J Nat Prod"},{"key":"5_CR25","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.3390\/molecules28073271","volume":"28","author":"J Castillo-Arellano","year":"2023","unstructured":"Castillo-Arellano J, Canseco-Alba A, Cutler SJ, Le\u00f3n F (2023) The polypharmacological effects of cannabidiol. Molecules 28:3271. https:\/\/doi.org\/10.3390\/molecules28073271","journal-title":"Molecules"},{"key":"5_CR26","doi-asserted-by":"publisher","first-page":"18658","DOI":"10.1038\/s41598-022-23506-0","volume":"12","author":"D Chelminiak-Dudkiewicz","year":"2022","unstructured":"Chelminiak-Dudkiewicz D, Smolarkiewicz-Wyczachowski A, Mylkie K, Wujak M et al (2022) Chitosan-based films with cannabis oil as a base material for wound dressing application. Sci Rep 12:18658. https:\/\/doi.org\/10.1038\/s41598-022-23506-0","journal-title":"Sci Rep"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejps.2017.07.003","volume":"109","author":"I Cherniakov","year":"2017","unstructured":"Cherniakov I, Izgelov D, Domb AJ, Hoffman A (2017) The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model. Eur J Pharm Sci 109:21\u201330. https:\/\/doi.org\/10.1016\/j.ejps.2017.07.003","journal-title":"Eur J Pharm Sci"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41577-018-0061-z","volume":"18","author":"L Chiossone","year":"2018","unstructured":"Chiossone L, Dumas PY, Vienne M, Vivier E (2018) Natural killer cells and other innate lymphoid cells in cancer. Nat Rev Immunol 18:671\u2013688. https:\/\/doi.org\/10.1038\/s41577-018-0061-z","journal-title":"Nat Rev Immunol"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/imm.12441","volume":"144","author":"V Chiurchi\u00f9","year":"2015","unstructured":"Chiurchi\u00f9 V, Battistini L, Maccarrone M (2015) Endocannabinoid signalling in innate and adaptive immunity. Immunology 144:352\u2013364. https:\/\/doi.org\/10.1111\/imm.12441","journal-title":"Immunology"},{"key":"5_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024793","volume":"9","author":"CT Costiniuk","year":"2019","unstructured":"Costiniuk CT, Saneei Z, Routy JP, Margolese S et al (2019) Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation. BMJ Open 9:e024793. https:\/\/doi.org\/10.1136\/bmjopen-2018-024793","journal-title":"BMJ Open"},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1042\/cs20171288","volume":"131","author":"DG Couch","year":"2017","unstructured":"Couch DG, Tasker C, Theophilidou E, Lund JN et al (2017) Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon. Clin Sci (Lond) 131:2611\u20132626. https:\/\/doi.org\/10.1042\/cs20171288","journal-title":"Clin Sci (Lond)"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.rdc.2022.02.010","volume":"48","author":"JJ Cush","year":"2022","unstructured":"Cush JJ (2022) Rheumatoid Arthritis: Early Diagnosis and Treatment. Rheum Dis Clin North Am 48:537\u2013547. https:\/\/doi.org\/10.1016\/j.rdc.2022.02.010","journal-title":"Rheum Dis Clin North Am"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/0024-3205(76)90315-5","volume":"19","author":"P Cushman Jr","year":"1976","unstructured":"Cushman P Jr (1976) Cannabinols and the rosette forming properties of lymphocytes in vitro. Life Sci 19:875\u2013885. https:\/\/doi.org\/10.1016\/0024-3205(76)90315-5","journal-title":"Life Sci"},{"key":"5_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.682","volume":"8","author":"DL de Almeida","year":"2020","unstructured":"de Almeida DL, Devi LA (2020) Diversity of molecular targets and signaling pathways for CBD. Pharmacol Res Perspect 8:e00682. https:\/\/doi.org\/10.1002\/prp2.682","journal-title":"Pharmacol Res Perspect"},{"key":"5_CR35","doi-asserted-by":"publisher","unstructured":"Deabold KA, Schwark WS, Wolf L, Wakshlag JJ (2019) Single-dose pharmacokinetics and preliminary safety assessment with use of CBD-rich hemp nutraceutical in healthy dogs and cats. Animals (Basel) 9. https:\/\/doi.org\/10.3390\/ani9100832","DOI":"10.3390\/ani9100832"},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1111\/bph.14450","volume":"175","author":"C Del Rio","year":"2018","unstructured":"Del Rio C, Cantarero I, Palomares B, G\u00f3mez-Ca\u00f1as M et al (2018) VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPAR\u03b3- and CB(2) receptor-dependent pathways. Br J Pharmacol 175:3813\u20133831. https:\/\/doi.org\/10.1111\/bph.14450","journal-title":"Br J Pharmacol"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/1574884711666160511150126","volume":"11","author":"N Derakhshan","year":"2016","unstructured":"Derakhshan N, Kazemi M (2016) Cannabis for refractory psoriasis\u2014High hopes for a novel treatment and a literature review. Curr Clin Pharmacol 11:146\u2013147. https:\/\/doi.org\/10.2174\/1574884711666160511150126","journal-title":"Curr Clin Pharmacol"},{"key":"5_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37373","volume":"10","author":"F Dernaika","year":"2024","unstructured":"Dernaika F, Halawy L, Zeaiter J, Kawrani S et al (2024) Development and characterization of a zeolite based drug delivery system: Application to cannabidiol oral delivery. Heliyon 10:e37373. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37373","journal-title":"Heliyon"},{"key":"5_CR39","doi-asserted-by":"publisher","first-page":"e1204","DOI":"10.1212\/wnl.0000000000005254","volume":"90","author":"O Devinsky","year":"2018","unstructured":"Devinsky O, Patel AD, Thiele EA, Wong MH et al (2018) Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome. Neurology 90:e1204\u2013e1211. https:\/\/doi.org\/10.1212\/wnl.0000000000005254","journal-title":"Neurology"},{"key":"5_CR40","doi-asserted-by":"publisher","unstructured":"Di Marzo V, Piscitelli F, Mechoulam R (2011) Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. Handb Exp Pharmacol 75\u2013104. https:\/\/doi.org\/10.1007\/978-3-642-17214-4_4","DOI":"10.1007\/978-3-642-17214-4_4"},{"key":"5_CR41","doi-asserted-by":"publisher","first-page":"1204526","DOI":"10.3389\/fvets.2023.1204526","volume":"10","author":"A Di Salvo","year":"2023","unstructured":"Di Salvo A, Conti MB, Della Rocca G (2023) Pharmacokinetics, efficacy, and safety of cannabidiol in dogs: an update of current knowledge. Frontiers in Veterinary Science 10:1204526","journal-title":"Frontiers in Veterinary Science"},{"key":"5_CR42","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2147\/dddt.S497323","volume":"19","author":"T Dong","year":"2025","unstructured":"Dong T, Li J, Liang X, Wang W et al (2025) Cannabidiol Ameliorates Doxorubicin-Induced Myocardial Injury via Activating Hippo Pathway. Drug des Devel Ther 19:569\u2013583. https:\/\/doi.org\/10.2147\/dddt.S497323","journal-title":"Drug des Devel Ther"},{"key":"5_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11481-021-10023-6","volume":"17","author":"N Dopkins","year":"2022","unstructured":"Dopkins N, Miranda K, Wilson K, Holloman BL et al (2022) Effects of Orally Administered Cannabidiol on Neuroinflammation and Intestinal Inflammation in the Attenuation of Experimental Autoimmune Encephalomyelitis. J Neuroimmune Pharmacol 17:15\u201332. https:\/\/doi.org\/10.1007\/s11481-021-10023-6","journal-title":"J Neuroimmune Pharmacol"},{"key":"5_CR44","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/glia.23738","volume":"68","author":"M Dos-Santos-Pereira","year":"2020","unstructured":"Dos-Santos-Pereira M, Guimar\u00e3es FS, Del-Bel E, Raisman-Vozari R et al (2020) Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS\/NF-\u03baB-dependent signaling and glucose consumption. Glia 68:561\u2013573. https:\/\/doi.org\/10.1002\/glia.23738","journal-title":"Glia"},{"key":"5_CR45","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/1523-1747.ep12483971","volume":"97","author":"MR Duncan","year":"1991","unstructured":"Duncan MR, Berman B (1991) Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. J Invest Dermatol 97:686\u2013692. https:\/\/doi.org\/10.1111\/1523-1747.ep12483971","journal-title":"J Invest Dermatol"},{"key":"5_CR46","first-page":"356","volume":"22","author":"M Dziadzio","year":"2004","unstructured":"Dziadzio M, Smith RE, Abraham DJ, Stratton RJ et al (2004) Serological assessment of type I collagen burden in scleroderma spectrum disorders: a systematic review. Clin Exp Rheumatol 22:356\u2013367","journal-title":"Clin Exp Rheumatol"},{"key":"5_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cscee.2024.100732","volume":"9","author":"M El Oihabi","year":"2024","unstructured":"El Oihabi M, Soultana M, Ammari M, Allal LB et al (2024) Diversity and variability of bioactive compounds in Cannabis sativa: Effects on therapeutic and environmental uses and orientations for future research. Case Studies in Chemical and Environmental Engineering 9:100732. https:\/\/doi.org\/10.1016\/j.cscee.2024.100732","journal-title":"Case Studies in Chemical and Environmental Engineering"},{"key":"5_CR48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neuron.2005.11.027","volume":"49","author":"E Eljaschewitsch","year":"2006","unstructured":"Eljaschewitsch E, Witting A, Mawrin C, Lee T et al (2006) The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49:67\u201379. https:\/\/doi.org\/10.1016\/j.neuron.2005.11.027","journal-title":"Neuron"},{"key":"5_CR49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/2049463717710042","volume":"11","author":"MT Fallon","year":"2017","unstructured":"Fallon MT, Albert Lux E, McQuade R, Rossetti S et al (2017) Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies. Br J Pain 11:119\u2013133. https:\/\/doi.org\/10.1177\/2049463717710042","journal-title":"Br J Pain"},{"key":"5_CR50","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s11101-023-09860-5","volume":"22","author":"BP Ferreira","year":"2023","unstructured":"Ferreira BP, Costa G, Mascarenhas-Melo F, Pires PC et al (2023) Skin applications of cannabidiol: sources, effects, delivery systems, marketed formulations and safety. Phytochem Rev 22:781\u2013828. https:\/\/doi.org\/10.1007\/s11101-023-09860-5","journal-title":"Phytochem Rev"},{"key":"5_CR51","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/all.13107","volume":"72","author":"ME Ferrini","year":"2017","unstructured":"Ferrini ME, Hong S, Stierle A, Stierle D et al (2017) CB2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthma. Allergy 72:937\u2013947. https:\/\/doi.org\/10.1111\/all.13107","journal-title":"Allergy"},{"key":"5_CR52","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/all.12858","volume":"71","author":"RB Frei","year":"2016","unstructured":"Frei RB, Luschnig P, Parzmair GP, Peinhaupt M et al (2016) Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen-induced pulmonary inflammation in mice. Allergy 71:944\u2013956. https:\/\/doi.org\/10.1111\/all.12858","journal-title":"Allergy"},{"key":"5_CR53","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2174\/1568010054022024","volume":"4","author":"N Fujiwara","year":"2005","unstructured":"Fujiwara N, Kobayashi K (2005) Macrophages in inflammation. Current Drug Targets-Inflammation & Allergy 4:281\u2013286. https:\/\/doi.org\/10.2174\/1568010054022024","journal-title":"Current Drug Targets-Inflammation & Allergy"},{"key":"5_CR54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-immunol-071719-094903","volume":"38","author":"SJ Galli","year":"2020","unstructured":"Galli SJ, Gaudenzio N, Tsai M (2020) Mast Cells in Inflammation and Disease: Recent Progress and Ongoing Concerns. Annu Rev Immunol 38:49\u201377. https:\/\/doi.org\/10.1146\/annurev-immunol-071719-094903","journal-title":"Annu Rev Immunol"},{"key":"5_CR55","doi-asserted-by":"publisher","first-page":"16546","DOI":"10.1074\/jbc.ra118.004929","volume":"293","author":"M-R Ghovanloo","year":"2018","unstructured":"Ghovanloo M-R, Shuart NG, Mezeyova J, Dean RA et al (2018) Inhibitory effects of cannabidiol on voltage-dependent sodium currents. J Biol Chem 293:16546\u201316558. https:\/\/doi.org\/10.1074\/jbc.ra118.004929","journal-title":"J Biol Chem"},{"key":"5_CR56","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1189\/jlb.1206738","volume":"81","author":"ED Giudice","year":"2007","unstructured":"Giudice ED, Rinaldi L, Passarotto M, Facchinetti F et al (2007) Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells. J Leukoc Biol 81:1512\u20131522. https:\/\/doi.org\/10.1189\/jlb.1206738","journal-title":"J Leukoc Biol"},{"key":"5_CR57","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2500\/108854186778984718","volume":"7","author":"GJ Gleich","year":"1986","unstructured":"Gleich GJ (1986) The pathology of asthma: with emphasis on the role of the eosinophil. N Engl Reg Allergy Proc 7:421\u2013424. https:\/\/doi.org\/10.2500\/108854186778984718","journal-title":"N Engl Reg Allergy Proc"},{"key":"5_CR58","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/BOR.0b013e328349c2b1","volume":"23","author":"MB Goldring","year":"2011","unstructured":"Goldring MB, Otero M (2011) Inflammation in osteoarthritis. Curr Opin Rheumatol 23:471\u2013478. https:\/\/doi.org\/10.1097\/BOR.0b013e328349c2b1","journal-title":"Curr Opin Rheumatol"},{"key":"5_CR59","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12904-019-0494-6","volume":"18","author":"P Good","year":"2019","unstructured":"Good P, Haywood A, Gogna G, Martin J et al (2019) Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD). BMC Palliat Care 18:110. https:\/\/doi.org\/10.1186\/s12904-019-0494-6","journal-title":"BMC Palliat Care"},{"key":"5_CR60","doi-asserted-by":"publisher","unstructured":"Go\u015bciniak A, Kocaj F, Stasi\u0142owicz-Krzemie\u0144 A, Szyma\u0144ski M et al (2024) 3D printed bigel: A novel delivery system for cannabidiol-rich hemp extract. Gels 10: https:\/\/doi.org\/10.3390\/gels10120770","DOI":"10.3390\/gels10120770"},{"key":"5_CR61","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.2147\/ijgm.S275049","volume":"13","author":"S Gottschling","year":"2020","unstructured":"Gottschling S, Ayonrinde O, Bhaskar A, Blockman M et al (2020) Safety Considerations in Cannabinoid-Based Medicine. Int J Gen Med 13:1317\u20131333. https:\/\/doi.org\/10.2147\/ijgm.S275049","journal-title":"Int J Gen Med"},{"key":"5_CR62","doi-asserted-by":"publisher","unstructured":"Green R, Khalil R, Mohapatra S S and Mohapatra S, (2022) Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges. Int J Mol Sci 23: https:\/\/doi.org\/10.3390\/ijms232112956","DOI":"10.3390\/ijms232112956"},{"key":"5_CR63","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028197","volume":"9","author":"O Hendricks","year":"2019","unstructured":"Hendricks O, Andersen TE, Christiansen AA, Primdahl J et al (2019) Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled study. BMJ Open 9:e028197. https:\/\/doi.org\/10.1136\/bmjopen-2018-028197","journal-title":"BMJ Open"},{"key":"5_CR64","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1021\/ja00960a056","volume":"88","author":"RL Hively","year":"1966","unstructured":"Hively RL, Mosher WA, Hoffmann FW (1966) Isolation of trans-\u03946-tetrahydrocannabinol from marijuana. J Am Chem Soc 88:1832\u20131833","journal-title":"J Am Chem Soc"},{"key":"5_CR65","doi-asserted-by":"publisher","first-page":"21224","DOI":"10.1002\/jcp.28728","volume":"234","author":"Y Huang","year":"2019","unstructured":"Huang Y, Wan T, Pang N, Zhou Y et al (2019) Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high-fat high cholesterol diet via regulating NF-\u03baB and NLRP3 inflammasome pathway. J Cell Physiol 234:21224\u201321234. https:\/\/doi.org\/10.1002\/jcp.28728","journal-title":"J Cell Physiol"},{"key":"5_CR66","doi-asserted-by":"publisher","first-page":"974","DOI":"10.2174\/1570159x17666190603171901","volume":"17","author":"MA Huestis","year":"2019","unstructured":"Huestis MA, Solimini R, Pichini S, Pacifici R et al (2019) Cannabidiol Adverse Effects and Toxicity. Curr Neuropharmacol 17:974\u2013989. https:\/\/doi.org\/10.2174\/1570159x17666190603171901","journal-title":"Curr Neuropharmacol"},{"key":"5_CR67","doi-asserted-by":"publisher","unstructured":"Ibrahim IA, Xu J, Robertson J, Ajayi BKO (2023) Exploring the synergy of carbon nanodots in enhancing cannabidiol delivery and therapeutic efficacy: A Comprehensive Review.\u00a0\u00a0https:\/\/doi.org\/10.20944\/preprints202310.1434.v1","DOI":"10.20944\/preprints202310.1434.v1"},{"key":"5_CR68","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/ibd\/izy002","volume":"24","author":"PM Irving","year":"2018","unstructured":"Irving PM, Iqbal T, Nwokolo C, Subramanian S et al (2018) A randomized, double-blind, placebo-controlled, parallel-group, pilot study of cannabidiol-rich botanical extract in the symptomatic treatment of ulcerative colitis. Inflamm Bowel Dis 24:714\u2013724. https:\/\/doi.org\/10.1093\/ibd\/izy002","journal-title":"Inflamm Bowel Dis"},{"key":"5_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.821758","volume":"13","author":"D Isaev","year":"2022","unstructured":"Isaev D, Shabbir W, Dinc EY, Lorke DE et al (2022) Cannabidiol inhibits multiple ion channels in rabbit ventricular cardiomyocytes. Front Pharmacol 13:821758. https:\/\/doi.org\/10.3389\/fphar.2022.821758","journal-title":"Front Pharmacol"},{"key":"5_CR70","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ni.3123","volume":"16","author":"A Iwasaki","year":"2015","unstructured":"Iwasaki A, Medzhitov R (2015) Control of adaptive immunity by the innate immune system. Nat Immunol 16:343\u2013353. https:\/\/doi.org\/10.1038\/ni.3123","journal-title":"Nat Immunol"},{"key":"5_CR71","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.neuroscience.2005.02.045","volume":"134","author":"SJ Jackson","year":"2005","unstructured":"Jackson SJ, Pryce G, Diemel LT, Cuzner ML et al (2005) Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation. Neuroscience 134:261\u2013268. https:\/\/doi.org\/10.1016\/j.neuroscience.2005.02.045","journal-title":"Neuroscience"},{"key":"5_CR72","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jneuroim.2008.12.004","volume":"207","author":"M Jenny","year":"2009","unstructured":"Jenny M, Santer E, Pirich E, Schennach H et al (2009) Delta9-tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro. J Neuroimmunol 207:75\u201382. https:\/\/doi.org\/10.1016\/j.jneuroim.2008.12.004","journal-title":"J Neuroimmunol"},{"key":"5_CR73","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.lfs.2011.05.018","volume":"89","author":"R Jiang","year":"2011","unstructured":"Jiang R, Yamaori S, Takeda S, Yamamoto I et al (2011) Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes. Life Sci 89:165\u2013170. https:\/\/doi.org\/10.1016\/j.lfs.2011.05.018","journal-title":"Life Sci"},{"key":"5_CR74","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/jcb.21046","volume":"100","author":"DR Johnson","year":"2007","unstructured":"Johnson DR, Stebulis JA, Rossetti RG, Burstein SH et al (2007) Suppression of fibroblast metalloproteinases by ajulemic acid, a nonpsychoactive cannabinoid acid. J Cell Biochem 100:184\u2013190. https:\/\/doi.org\/10.1002\/jcb.21046","journal-title":"J Cell Biochem"},{"key":"5_CR75","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1111\/j.1476-5381.2011.01461.x","volume":"165","author":"A Juknat","year":"2012","unstructured":"Juknat A, Pietr M, Kozela E, Rimmerman N et al (2012) Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and \u03949-tetrahydrocannabinol in BV-2 microglial cells. Br J Pharmacol 165:2512\u20132528. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01461.x","journal-title":"Br J Pharmacol"},{"key":"5_CR76","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s41061-024-00465-w","volume":"382","author":"I Kalsoom","year":"2024","unstructured":"Kalsoom I, Shehzadi K, Li H-s, Wen H-l et al (2024) Unraveling the Mechanisms of Cannabidiol\u2019s Pharmacological Actions: A Comprehensive Research Overview. Top Curr Chem 382:20. https:\/\/doi.org\/10.1007\/s41061-024-00465-w","journal-title":"Top Curr Chem"},{"key":"5_CR77","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1124\/jpet.103.051961","volume":"306","author":"BL Kaplan","year":"2003","unstructured":"Kaplan BL, Rockwell CE, Kaminski NE (2003) Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes. J Pharmacol Exp Ther 306:1077\u20131085. https:\/\/doi.org\/10.1124\/jpet.103.051961","journal-title":"J Pharmacol Exp Ther"},{"key":"5_CR78","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s00210-006-0033-x","volume":"372","author":"M Kathmann","year":"2006","unstructured":"Kathmann M, Flau K, Redmer A, Tr\u00e4nkle C et al (2006) Cannabidiol is an allosteric modulator at mu-and delta-opioid receptors. Naunyn Schmiedebergs Arch Pharmacol 372:354\u2013361. https:\/\/doi.org\/10.1007\/s00210-006-0033-x","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5_CR79","doi-asserted-by":"publisher","unstructured":"Khuja I, Yekhtin Z, Or R, Almogi-Hazan O (2019) Cannabinoids reduce inflammation but inhibit lymphocyte recovery in murine models of bone marrow transplantation. Int J Mol Sci 20. https:\/\/doi.org\/10.3390\/ijms20030668","DOI":"10.3390\/ijms20030668"},{"key":"5_CR80","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jff.2014.09.021","volume":"11","author":"K-A Kim","year":"2014","unstructured":"Kim K-A, Jang S-E, Jeong J-J, Yu D-H et al (2014) Doenjang, a Korean soybean paste, ameliorates TNBS-induced colitis in mice by suppressing gut microbial lipopolysaccharide production and NF-\u03baB activation. Journal of Functional Foods 11:417\u2013427. https:\/\/doi.org\/10.1016\/j.jff.2014.09.021","journal-title":"Journal of Functional Foods"},{"key":"5_CR81","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/jb\/mvi021","volume":"137","author":"S Kishimoto","year":"2005","unstructured":"Kishimoto S, Muramatsu M, Gokoh M, Oka S et al (2005) Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells. J Biochem 137:217\u2013223. https:\/\/doi.org\/10.1093\/jb\/mvi021","journal-title":"J Biochem"},{"key":"5_CR82","doi-asserted-by":"publisher","unstructured":"Knaub K, Sartorius T, Dharsono T, Wacker R et al (2019) A novel self-emulsifying drug delivery system (SEDDS) based on VESIsorb(\u00ae) formulation technology improving the oral bioavailability of cannabidiol in healthy subjects. Molecules 24. https:\/\/doi.org\/10.3390\/molecules24162967","DOI":"10.3390\/molecules24162967"},{"key":"5_CR83","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1152\/jn.00128.2020","volume":"124","author":"CW Kowalski","year":"2020","unstructured":"Kowalski CW, Ragozzino FJ, Lindberg JE, Peterson B et al (2020) Cannabidiol activation of vagal afferent neurons requires TRPA1. J Neurophysiol 124:1388\u20131398. https:\/\/doi.org\/10.1152\/jn.00128.2020","journal-title":"J Neurophysiol"},{"key":"5_CR84","doi-asserted-by":"publisher","unstructured":"Krishnaswamy G, Ajitawi O, Chi DS (2005) The human mast cell: an overview. Mast Cells: Methods and Protocols 13\u201334. https:\/\/doi.org\/10.1385\/1-59259-967-2:013","DOI":"10.1385\/1-59259-967-2:013"},{"key":"5_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105895","volume":"174","author":"E Landucci","year":"2022","unstructured":"Landucci E, Mazzantini C, Lana D, Calvani M et al (2022) Cannabidiol inhibits microglia activation and mitigates neuronal damage induced by kainate in an in-vitro seizure model. Neurobiol Dis 174:105895. https:\/\/doi.org\/10.1016\/j.nbd.2022.105895","journal-title":"Neurobiol Dis"},{"key":"5_CR86","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00109-011-0824-5","volume":"90","author":"PE Lazzerini","year":"2012","unstructured":"Lazzerini PE, Natale M, Gianchecchi E, Capecchi PL et al (2012) Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system. J Mol Med (Berl) 90:331\u2013342. https:\/\/doi.org\/10.1007\/s00109-011-0824-5","journal-title":"J Mol Med (Berl)"},{"key":"5_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173542","volume":"886","author":"M Le Marois","year":"2020","unstructured":"Le Marois M, Ballet V, Sanson C, Maizi\u00e8res MA et al (2020) Cannabidiol inhibits multiple cardiac ion channels and shortens ventricular action potential duration in vitro. Eur J Pharmacol 886:173542. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173542","journal-title":"Eur J Pharmacol"},{"key":"5_CR88","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000521683","volume":"107","author":"CA Legare","year":"2022","unstructured":"Legare CA, Raup-Konsavage WM, Vrana KE (2022) Therapeutic potential of cannabis, cannabidiol, and cannabinoid-based pharmaceuticals. Pharmacology 107:131\u2013149. https:\/\/doi.org\/10.1159\/000521683","journal-title":"Pharmacology"},{"key":"5_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024031","volume":"6","author":"SN Lewis","year":"2011","unstructured":"Lewis SN, Brannan L, Guri AJ, Lu P et al (2011) Dietary \u03b1-eleostearic acid ameliorates experimental inflammatory bowel disease in mice by activating peroxisome proliferator-activated receptor-\u03b3. PLoS ONE 6:e24031. https:\/\/doi.org\/10.1371\/journal.pone.0024031","journal-title":"PLoS ONE"},{"key":"5_CR90","doi-asserted-by":"publisher","unstructured":"Limberg MM, Weihrauch T, Gray N, Ernst N et al (2023) Eosinophils, basophils, and neutrophils in bullous pemphigoid. Biomolecules 13. https:\/\/doi.org\/10.3390\/biom13071019","DOI":"10.3390\/biom13071019"},{"key":"5_CR91","doi-asserted-by":"publisher","first-page":"1389810","DOI":"10.3389\/fvets.2024.1389810","volume":"11","author":"S Limsuwan","year":"2024","unstructured":"Limsuwan S, Phonsatta N, Panya A, Asasutjarit R et al (2024) Pharmacokinetics behavior of four cannabidiol preparations following single oral administration in dogs. Front Vet Sci 11:1389810. https:\/\/doi.org\/10.3389\/fvets.2024.1389810","journal-title":"Front Vet Sci"},{"key":"5_CR92","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1152\/physrev.00023.2001","volume":"82","author":"MF Lipscomb","year":"2002","unstructured":"Lipscomb MF, Masten BJ (2002) Dendritic cells: immune regulators in health and disease. Physiol Rev 82:97\u2013130. https:\/\/doi.org\/10.1152\/physrev.00023.2001","journal-title":"Physiol Rev"},{"key":"5_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2:1\u20139. https:\/\/doi.org\/10.1038\/sigtrans.2017.23","journal-title":"Signal Transduct Target Ther"},{"key":"5_CR94","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4783451","author":"B Liu","year":"2024","unstructured":"Liu B, Sun Y, Zhang H, Zhang H, Chang S, CHEN, C,\u2026& Jiang Y (2024) Nano-Cannabidiol to Orchestrate Inflammatory Homeostasis Via Macrophage Metabolism Reprogramming for Targeted Treatment Atherosclerosis. SSRN. https:\/\/doi.org\/10.2139\/ssrn.4783451","journal-title":"SSRN"},{"key":"5_CR95","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000517120","volume":"4","author":"RF Maguire","year":"2021","unstructured":"Maguire RF, Wilkinson DJ, England TJ, O\u2019Sullivan SE (2021) The pharmacological effects of plant-derived versus synthetic cannabidiol in human cell lines. Medical Cannabis and Cannabinoids 4:86\u201396. https:\/\/doi.org\/10.1159\/000517120","journal-title":"Medical Cannabis and Cannabinoids"},{"key":"5_CR96","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1124\/jpet.114.221283","volume":"353","author":"R Makwana","year":"2015","unstructured":"Makwana R, Venkatasamy R, Spina D, Page C (2015) The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough. J Pharmacol Exp Ther 353:169\u2013180. https:\/\/doi.org\/10.1124\/jpet.114.221283","journal-title":"J Pharmacol Exp Ther"},{"key":"5_CR97","doi-asserted-by":"publisher","first-page":"9561","DOI":"10.1073\/pnas.160105897","volume":"97","author":"AM Malfait","year":"2000","unstructured":"Malfait AM, Gallily R, Sumariwalla PF, Malik AS et al (2000) The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci U S A 97:9561\u20139566. https:\/\/doi.org\/10.1073\/pnas.160105897","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR98","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1196\/annals.1288.005","volume":"1005","author":"T Mandrup-Poulsen","year":"2003","unstructured":"Mandrup-Poulsen T (2003) Beta cell death and protection. Ann N Y Acad Sci 1005:32\u201342. https:\/\/doi.org\/10.1196\/annals.1288.005","journal-title":"Ann N Y Acad Sci"},{"key":"5_CR99","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1007\/s00432-021-03710-7","volume":"147","author":"N Mangal","year":"2021","unstructured":"Mangal N, Erridge S, Habib N, Sadanandam A et al (2021) Cannabinoids in the landscape of cancer. J Cancer Res Clin Oncol 147:2507\u20132534. https:\/\/doi.org\/10.1007\/s00432-021-03710-7","journal-title":"J Cancer Res Clin Oncol"},{"key":"5_CR100","doi-asserted-by":"publisher","unstructured":"Marinelli O, Morelli MB, Annibali D, Aguzzi C et al (2020) The effects of cannabidiol and prognostic role of TRPV2 in human endometrial cancer. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/ijms21155409","DOI":"10.3390\/ijms21155409"},{"key":"5_CR101","doi-asserted-by":"publisher","unstructured":"Markiewicz I and Lukomska B (2006) The role of astrocytes in the physiology and pathology of the central nervous system. Acta neurobiologiae experimentalis 66:343\u2013358. https:\/\/doi.org\/10.55782\/ane-2006-1623","DOI":"10.55782\/ane-2006-1623"},{"key":"5_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006893","volume":"4","author":"L Marqu\u00e9z","year":"2009","unstructured":"Marqu\u00e9z L, Su\u00e1rez J, Iglesias M, Bermudez-Silva FJ et al (2009) Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue. PLoS ONE 4:e6893. https:\/\/doi.org\/10.1371\/journal.pone.0006893","journal-title":"PLoS ONE"},{"key":"5_CR103","doi-asserted-by":"publisher","first-page":"5980","DOI":"10.3390\/molecules28165980","volume":"28","author":"N Martinez Naya","year":"2023","unstructured":"Martinez Naya N, Kelly J, Corna G, Golino M et al (2023) Molecular and cellular mechanisms of action of cannabidiol. Molecules 28:5980. https:\/\/doi.org\/10.3390\/molecules28165980","journal-title":"Molecules"},{"key":"5_CR104","doi-asserted-by":"publisher","unstructured":"Martini S, Gemma A, Ferrari M, Cosentino M et al (2023) Effects of cannabidiol on innate immunity: experimental evidence and clinical relevance. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms24043125","DOI":"10.3390\/ijms24043125"},{"key":"5_CR105","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1046\/j.1432-1033.2002.03078.x","volume":"269","author":"I Matias","year":"2002","unstructured":"Matias I, Pochard P, Orlando P, Salzet M et al (2002) Presence and regulation of the endocannabinoid system in human dendritic cells. Eur J Biochem 269:3771\u20133778. https:\/\/doi.org\/10.1046\/j.1432-1033.2002.03078.x","journal-title":"Eur J Biochem"},{"key":"5_CR106","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1038\/cddis.2012.71","volume":"3","author":"M Mecha","year":"2012","unstructured":"Mecha M, Torrao A, d S, Mestre L, Carrillo-Salinas F, et al (2012) Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress. Cell Death Dis 3:e331\u2013e331. https:\/\/doi.org\/10.1038\/cddis.2012.71","journal-title":"Cell Death Dis"},{"key":"5_CR107","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/0040-4020(63)85022-x","volume":"19","author":"R Mechoulam","year":"1963","unstructured":"Mechoulam R, Shvo Y (1963) Hashish. I the Structure of Cannabidiol Tetrahedron 19:2073\u20132078. https:\/\/doi.org\/10.1016\/0040-4020(63)85022-x","journal-title":"I the Structure of Cannabidiol Tetrahedron"},{"key":"5_CR108","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1080\/10428194.2021.2020776","volume":"63","author":"CM Mel\u00e9n","year":"2022","unstructured":"Mel\u00e9n CM, Merrien M, Wasik AM, Panagiotidis G et al (2022) Clinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia. Leuk Lymphoma 63:1387\u20131397. https:\/\/doi.org\/10.1080\/10428194.2021.2020776","journal-title":"Leuk Lymphoma"},{"key":"5_CR109","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3389\/fphar.2018.01365","volume":"9","author":"SA Millar","year":"2018","unstructured":"Millar SA, Stone NL, Yates AS, O\u2019Sullivan SE (2018) A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans. Front Pharmacol 9:1365. https:\/\/doi.org\/10.3389\/fphar.2018.01365","journal-title":"Front Pharmacol"},{"key":"5_CR110","doi-asserted-by":"publisher","unstructured":"Millar SA, Maguire RF, Yates AS, O'Sullivan SE (2020) Towards better delivery of cannabidiol (CBD). pharmaceuticals (Basel) 13. https:\/\/doi.org\/10.3390\/ph13090219","DOI":"10.3390\/ph13090219"},{"key":"5_CR111","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2329\/perio.63.11","volume":"63","author":"S Mishiro","year":"2021","unstructured":"Mishiro S, Igarashi-Takeuchi H, Numabe Y (2021) Expression of Cannabinoid Receptor GPR55 in Human Gingival Fibroblasts and Anti-inflammatory Effects of Cannabidiol via GPR55. Nihon Shishubyo Gakkai Kaishi (Journal of the Japanese Society of Periodontology) 63:11\u201323. https:\/\/doi.org\/10.2329\/perio.63.11","journal-title":"Nihon Shishubyo Gakkai Kaishi (Journal of the Japanese Society of Periodontology)"},{"key":"5_CR112","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.freeradbiomed.2011.02.021","volume":"50","author":"P Mukhopadhyay","year":"2011","unstructured":"Mukhopadhyay P, Rajesh M, Horv\u00e1th B, B\u00e1tkai S et al (2011) Cannabidiol protects against hepatic ischemia\/reperfusion injury by attenuating inflammatory signaling and response, oxidative\/nitrative stress, and cell death. Free Radic Biol Med 50:1368\u20131381. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.02.021","journal-title":"Free Radic Biol Med"},{"key":"5_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2019.114713","volume":"382","author":"T Muthumalage","year":"2019","unstructured":"Muthumalage T, Rahman I (2019) Cannabidiol differentially regulates basal and LPS-induced inflammatory responses in macrophages, lung epithelial cells, and fibroblasts. Toxicol Appl Pharmacol 382:114713. https:\/\/doi.org\/10.1016\/j.taap.2019.114713","journal-title":"Toxicol Appl Pharmacol"},{"key":"5_CR114","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1093\/jat\/29.8.782","volume":"29","author":"T Nadulski","year":"2005","unstructured":"Nadulski T, Sporkert F, Schnelle M, Stadelmann AM et al (2005) Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract. J Anal Toxicol 29:782\u2013789. https:\/\/doi.org\/10.1093\/jat\/29.8.782","journal-title":"J Anal Toxicol"},{"key":"5_CR115","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cgh.2013.04.034","volume":"11","author":"T Naftali","year":"2013","unstructured":"Naftali T, Bar-Lev Schleider L, Dotan I, Lansky EP et al (2013) Cannabis induces a clinical response in patients with Crohn\u2019s disease: a prospective placebo-controlled study. Clin Gastroenterol Hepatol 11:1276-1280.e1271. https:\/\/doi.org\/10.1016\/j.cgh.2013.04.034","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5_CR116","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1159\/000358155","volume":"32","author":"T Naftali","year":"2014","unstructured":"Naftali T, Mechulam R, Lev LB, Konikoff FM (2014) Cannabis for inflammatory bowel disease. Dig Dis 32:468\u2013474. https:\/\/doi.org\/10.1159\/000358155","journal-title":"Dig Dis"},{"key":"5_CR117","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/ecco-jcc\/jjab069","volume":"15","author":"T Naftali","year":"2021","unstructured":"Naftali T, Bar-Lev Schleider L, Almog S, Meiri D et al (2021) Oral CBD-rich Cannabis Induces Clinical but Not Endoscopic Response in Patients with Crohn\u2019s Disease, a Randomised Controlled Trial. J Crohns Colitis 15:1799\u20131806. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab069","journal-title":"J Crohns Colitis"},{"key":"5_CR118","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1124\/dmd.121.000442","volume":"49","author":"S Nasrin","year":"2021","unstructured":"Nasrin S, Watson CJ, Perez-Paramo YX, Lazarus P (2021) Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions. Drug Metab Dispos 49:1070\u20131080. https:\/\/doi.org\/10.1124\/dmd.121.000442","journal-title":"Drug Metab Dispos"},{"key":"5_CR119","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1089\/can.2018.0073","volume":"5","author":"JM Nichols","year":"2020","unstructured":"Nichols JM, Kaplan BLF (2020) Immune Responses Regulated by Cannabidiol. Cannabis Cannabinoid Res 5:12\u201331. https:\/\/doi.org\/10.1089\/can.2018.0073","journal-title":"Cannabis Cannabinoid Res"},{"key":"5_CR120","doi-asserted-by":"publisher","first-page":"9441","DOI":"10.1007\/s00520-022-07312-y","volume":"30","author":"SW Nielsen","year":"2022","unstructured":"Nielsen SW, Hasselsteen SD, Dominiak HSH, Labudovic D et al (2022) Oral cannabidiol for prevention of acute and transient chemotherapy-induced peripheral neuropathy. Support Care Cancer 30:9441\u20139451. https:\/\/doi.org\/10.1007\/s00520-022-07312-y","journal-title":"Support Care Cancer"},{"key":"5_CR121","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1189\/jlb.0404252","volume":"76","author":"S Oka","year":"2004","unstructured":"Oka S, Ikeda S, Kishimoto S, Gokoh M et al (2004) 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils. J Leukoc Biol 76:1002\u20131009. https:\/\/doi.org\/10.1189\/jlb.0404252","journal-title":"J Leukoc Biol"},{"key":"5_CR122","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/s0140-6736(00)04904-7","volume":"357","author":"J Parkin","year":"2001","unstructured":"Parkin J, Cohen B (2001) An overview of the immune system. The Lancet 357:1777\u20131789. https:\/\/doi.org\/10.1016\/s0140-6736(00)04904-7","journal-title":"The Lancet"},{"key":"5_CR123","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/s0024-3205(99)00286-6","volume":"65","author":"D Parolaro","year":"1999","unstructured":"Parolaro D (1999) Presence and functional regulation of cannabinoid receptors in immune cells. Life Sci 65:637\u2013644. https:\/\/doi.org\/10.1016\/s0024-3205(99)00286-6","journal-title":"Life Sci"},{"issue":"25949\/21555219","key":"5_CR124","volume":"10","author":"C Partalis","year":"2022","unstructured":"Partalis C (2022) Development of silica nanoparticle transdermal delivery systems for cannabidiol. Macquarie University 10(25949\/21555219):v1","journal-title":"Macquarie University"},{"key":"5_CR125","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1136\/jnnp-2015-312591","volume":"87","author":"F Patti","year":"2016","unstructured":"Patti F, Messina S, Solaro C, Amato MP et al (2016) Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity. J Neurol Neurosurg Psychiatry 87:944\u2013951. https:\/\/doi.org\/10.1136\/jnnp-2015-312591","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5_CR126","doi-asserted-by":"publisher","first-page":"1240800","DOI":"10.3389\/fimmu.2023.1240800","volume":"14","author":"Z P\u00e9nzes","year":"2023","unstructured":"P\u00e9nzes Z, Alimohammadi S, Horv\u00e1th D, Ol\u00e1h A et al (2023) The dual role of cannabidiol on monocyte-derived dendritic cell differentiation and maturation. Front Immunol 14:1240800. https:\/\/doi.org\/10.3389\/fimmu.2023.1240800","journal-title":"Front Immunol"},{"key":"5_CR127","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/s0301-0082(00)00031-9","volume":"63","author":"RG Pertwee","year":"2001","unstructured":"Pertwee RG (2001) Cannabinoid receptors and pain. Prog Neurobiol 63:569\u2013611. https:\/\/doi.org\/10.1016\/s0301-0082(00)00031-9","journal-title":"Prog Neurobiol"},{"key":"5_CR128","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1124\/jpet.117.244368","volume":"365","author":"S Petrosino","year":"2018","unstructured":"Petrosino S, Verde R, Vaia M, Allar\u00e0 M et al (2018) Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis. J Pharmacol Exp Ther 365:652\u2013663. https:\/\/doi.org\/10.1124\/jpet.117.244368","journal-title":"J Pharmacol Exp Ther"},{"key":"5_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.899940","volume":"9","author":"D Polidoro","year":"2022","unstructured":"Polidoro D, Temmerman R, Devreese M, Charalambous M et al (2022a) Pharmacokinetics of cannabidiol following intranasal, intrarectal, and oral administration in healthy dogs. Frontiers in Veterinary Science 9:899940","journal-title":"Frontiers in Veterinary Science"},{"key":"5_CR130","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.899940","volume":"9","author":"D Polidoro","year":"2022","unstructured":"Polidoro D, Temmerman R, Devreese M, Charalambous M et al (2022b) Pharmacokinetics of Cannabidiol Following Intranasal, Intrarectal, and Oral Administration in Healthy Dogs. Front Vet Sci 9:899940. https:\/\/doi.org\/10.3389\/fvets.2022.899940","journal-title":"Front Vet Sci"},{"key":"5_CR131","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jpain.2012.01.003","volume":"13","author":"RK Portenoy","year":"2012","unstructured":"Portenoy RK, Ganae-Motan ED, Allende S, Yanagihara R et al (2012) Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. J Pain 13:438\u2013449. https:\/\/doi.org\/10.1016\/j.jpain.2012.01.003","journal-title":"J Pain"},{"key":"5_CR132","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/sj.bjp.0707003","volume":"150","author":"G Pryce","year":"2007","unstructured":"Pryce G, Baker D (2007) Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors. Br J Pharmacol 150:519\u2013525. https:\/\/doi.org\/10.1038\/sj.bjp.0707003","journal-title":"Br J Pharmacol"},{"key":"5_CR133","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1093\/brain\/awg224","volume":"126","author":"G Pryce","year":"2003","unstructured":"Pryce G, Ahmed Z, Hankey DJ, Jackson SJ et al (2003) Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain 126:2191\u20132202. https:\/\/doi.org\/10.1093\/brain\/awg224","journal-title":"Brain"},{"key":"5_CR134","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.40","volume":"1","author":"Y Ramot","year":"2013","unstructured":"Ramot Y, Sugawara K, Z\u00e1k\u00e1ny N, T\u00f3th BI et al (2013) A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ. PeerJ 1:e40. https:\/\/doi.org\/10.7717\/peerj.40","journal-title":"PeerJ"},{"key":"5_CR135","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejphar.2011.12.043","volume":"678","author":"A Ribeiro","year":"2012","unstructured":"Ribeiro A, Ferraz-de-Paula V, Pinheiro ML, Vitoretti LB et al (2012) Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor. Eur J Pharmacol 678:78\u201385. https:\/\/doi.org\/10.1016\/j.ejphar.2011.12.043","journal-title":"Eur J Pharmacol"},{"key":"5_CR136","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1186\/ar2401","volume":"10","author":"D Richardson","year":"2008","unstructured":"Richardson D, Pearson RG, Kurian N, Latif ML et al (2008) Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther 10:R43. https:\/\/doi.org\/10.1186\/ar2401","journal-title":"Arthritis Res Ther"},{"key":"5_CR137","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1124\/mol.106.023937","volume":"70","author":"M Rj","year":"2006","unstructured":"Rj M (2006) Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression. Mol Pharmacol 70:897\u2013908. https:\/\/doi.org\/10.1124\/mol.106.023937","journal-title":"Mol Pharmacol"},{"key":"5_CR138","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1212\/01.wnl.0000176753.45410.8b","volume":"65","author":"DJ Rog","year":"2005","unstructured":"Rog DJ, Nurmikko TJ, Friede T, Young CA (2005) Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 65:812\u2013819. https:\/\/doi.org\/10.1212\/01.wnl.0000176753.45410.8b","journal-title":"Neurology"},{"key":"5_CR139","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","volume":"30","author":"EB Russo","year":"2005","unstructured":"Russo EB, Burnett A, Hall B, Parker KK (2005) Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem Res 30:1037\u20131043. https:\/\/doi.org\/10.1007\/s11064-005-6978-1","journal-title":"Neurochem Res"},{"key":"5_CR140","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jneuroim.2004.10.003","volume":"159","author":"P Sacerdote","year":"2005","unstructured":"Sacerdote P, Martucci C, Vaccani A, Bariselli F et al (2005) The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro. J Neuroimmunol 159:97\u2013105. https:\/\/doi.org\/10.1016\/j.jneuroim.2004.10.003","journal-title":"J Neuroimmunol"},{"key":"5_CR141","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nri3086","volume":"11","author":"K Saijo","year":"2011","unstructured":"Saijo K, Glass CK (2011) Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 11:775\u2013787. https:\/\/doi.org\/10.1038\/nri3086","journal-title":"Nat Rev Immunol"},{"key":"5_CR142","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0090-9556(25)06962-4","volume":"16","author":"E Samara","year":"1988","unstructured":"Samara E, Bialer M, Mechoulam R (1988) Pharmacokinetics of cannabidiol in dogs. Drug Metab Dispos 16:469\u2013472. https:\/\/doi.org\/10.1016\/S0090-9556(25)06962-4","journal-title":"Drug Metab Dispos"},{"key":"5_CR143","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/bdd.2510110906","volume":"11","author":"E Samara","year":"1990","unstructured":"Samara E, Bialer M, Harvey DJ (1990) Pharmacokinetics of urinary metabolites of cannabidiol in the dog. Biopharm Drug Dispos 11:785\u2013795. https:\/\/doi.org\/10.1002\/bdd.2510110906","journal-title":"Biopharm Drug Dispos"},{"key":"5_CR144","first-page":"528","volume":"57","author":"J Satoh","year":"1999","unstructured":"Satoh J, Takahashi K, Nakazawa T, Sakata Y et al (1999) Current concept of the pathogenesis of autoimmune type 1 diabetes mellitus. Nihon Rinsho 57:528\u2013533","journal-title":"Nihon Rinsho"},{"key":"5_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000356512","volume":"93","author":"R Schicho","year":"2014","unstructured":"Schicho R, Storr M (2014) Cannabis finds its way into treatment of Crohn\u2019s disease. Pharmacology 93:1\u20133. https:\/\/doi.org\/10.1159\/000356512","journal-title":"Pharmacology"},{"key":"5_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108586","volume":"191","author":"AK Schlag","year":"2021","unstructured":"Schlag AK, O\u2019Sullivan SE, Zafar RR, Nutt DJ (2021) Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics. Neuropharmacology 191:108586. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108586","journal-title":"Neuropharmacology"},{"key":"5_CR147","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1373\/clinchem.2011.171777","volume":"57","author":"DM Schwope","year":"2011","unstructured":"Schwope DM, Karschner EL, Gorelick DA, Huestis MA (2011) Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration. Clin Chem 57:1406\u20131414. https:\/\/doi.org\/10.1373\/clinchem.2011.171777","journal-title":"Clin Chem"},{"key":"5_CR148","first-page":"574","volume":"26","author":"E Selvi","year":"2008","unstructured":"Selvi E, Lorenzini S, Garcia-Gonzalez E, Maggio R et al (2008) Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes. Clin Exp Rheumatol 26:574\u2013581","journal-title":"Clin Exp Rheumatol"},{"key":"5_CR149","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40824-023-00390-x","volume":"27","author":"J Shi","year":"2023","unstructured":"Shi J, Ma Q, Su W, Liu C et al (2023) Effervescent cannabidiol solid dispersion-doped dissolving microneedles for boosted melanoma therapy via the \u201cTRPV1-NFATc1-ATF3\u201d pathway and tumor microenvironment engineering. Biomater Res 27:48. https:\/\/doi.org\/10.1186\/s40824-023-00390-x","journal-title":"Biomater Res"},{"key":"5_CR150","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2174\/0126673878300347240718100814","volume":"18","author":"V Singh","year":"2024","unstructured":"Singh V, Vihal S, Rana R, Rathore C (2024) Nanocarriers for Cannabinoid Delivery: Enhancing Therapeutic Potential. Recent Adv Drug Deliv Formul 18:247\u2013261. https:\/\/doi.org\/10.2174\/0126673878300347240718100814","journal-title":"Recent Adv Drug Deliv Formul"},{"key":"5_CR151","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.4049\/jimmunol.156.3.1196","volume":"156","author":"MJ Skeen","year":"1996","unstructured":"Skeen MJ, Miller MA, Shinnick TM, Ziegler HK (1996) Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. J Immunol 156:1196\u20131206","journal-title":"J Immunol"},{"key":"5_CR152","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/glia.23116","volume":"65","author":"N Snaidero","year":"2017","unstructured":"Snaidero N, Simons M (2017) The logistics of myelin biogenesis in the central nervous system. Glia 65:1021\u20131031. https:\/\/doi.org\/10.1002\/glia.23116","journal-title":"Glia"},{"key":"5_CR153","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/jvp.13026","volume":"44","author":"AP Spittler","year":"2021","unstructured":"Spittler AP, Helbling JE, McGrath S, Gustafson DL et al (2021) Plasma and joint tissue pharmacokinetics of two doses of oral cannabidiol oil in guinea pigs (Cavia porcellus). J Vet Pharmacol Ther 44:967\u2013974. https:\/\/doi.org\/10.1111\/jvp.13026","journal-title":"J Vet Pharmacol Ther"},{"key":"5_CR154","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/ptt.S469698","volume":"14","author":"AMA Stanescu","year":"2024","unstructured":"Stanescu AMA, Bejan GC, Balta MD, Andronic O et al (2024) The Perspective of Cannabidiol in Psoriasis Therapy. Psoriasis (Auckl) 14:51\u201361. https:\/\/doi.org\/10.2147\/ptt.S469698","journal-title":"Psoriasis (Auckl)"},{"key":"5_CR155","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/j.jaci.2009.11.017","volume":"125","author":"KD Stone","year":"2010","unstructured":"Stone KD, Prussin C, Metcalfe DD (2010) IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 125:S73-80. https:\/\/doi.org\/10.1016\/j.jaci.2009.11.017","journal-title":"J Allergy Clin Immunol"},{"key":"5_CR156","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/art.20050","volume":"50","author":"PF Sumariwalla","year":"2004","unstructured":"Sumariwalla PF, Gallily R, Tchilibon S, Fride E et al (2004) A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis. Arthritis Rheum 50:985\u2013998. https:\/\/doi.org\/10.1002\/art.20050","journal-title":"Arthritis Rheum"},{"key":"5_CR157","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/s0960-9822(95)00170-9","volume":"5","author":"SL Swain","year":"1995","unstructured":"Swain SL (1995) T-cell subsets. Who does the polarizing? Curr Biol 5:849\u2013851. https:\/\/doi.org\/10.1016\/s0960-9822(95)00170-9","journal-title":"Curr Biol"},{"key":"5_CR158","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","volume":"32","author":"L Taylor","year":"2018","unstructured":"Taylor L, Gidal B, Blakey G, Tayo B et al (2018) A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects. CNS Drugs 32:1053\u20131067. https:\/\/doi.org\/10.1007\/s40263-018-0578-5","journal-title":"CNS Drugs"},{"key":"5_CR159","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1089\/can.2017.0041","volume":"3","author":"D Thapa","year":"2018","unstructured":"Thapa D, Cairns EA, Szczesniak AM, Toguri JT et al (2018) The Cannabinoids \u0394(8)THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation. Cannabis Cannabinoid Res 3:11\u201320. https:\/\/doi.org\/10.1089\/can.2017.0041","journal-title":"Cannabis Cannabinoid Res"},{"key":"5_CR160","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","volume":"150","author":"A Thomas","year":"2007","unstructured":"Thomas A, Baillie G, Phillips A, Razdan R et al (2007) Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. Br J Pharmacol 150:613\u2013623. https:\/\/doi.org\/10.1038\/sj.bjp.0707133","journal-title":"Br J Pharmacol"},{"key":"5_CR161","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.926696","volume":"13","author":"S Tomer","year":"2022","unstructured":"Tomer S, Mu W, Suryawanshi G, Ng H et al (2022) Cannabidiol modulates expression of type I IFN response genes and HIV infection in macrophages. Front Immunol 13:926696. https:\/\/doi.org\/10.3389\/fimmu.2022.926696","journal-title":"Front Immunol"},{"key":"5_CR162","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nri1001","volume":"3","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3:133\u2013146. https:\/\/doi.org\/10.1038\/nri1001","journal-title":"Nat Rev Immunol"},{"key":"5_CR163","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1089\/can.2023.0237","volume":"9","author":"SG Tsiogkas","year":"2024","unstructured":"Tsiogkas SG, Apostolopoulou K, Papagianni ED, Mavropoulos A et al (2024) Cannabidiol Mediates In Vitro Attenuation of Proinflammatory Cytokine Responses in Psoriatic Disease. Cannabis and Cannabinoid Research 9:134\u2013146. https:\/\/doi.org\/10.1089\/can.2023.0237","journal-title":"Cannabis and Cannabinoid Research"},{"key":"5_CR164","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1089\/can.2015.0012","volume":"1","author":"I Ujv\u00e1ry","year":"2016","unstructured":"Ujv\u00e1ry I, Hanu\u0161 L (2016) Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy. Cannabis Cannabinoid Res 1:90\u2013101. https:\/\/doi.org\/10.1089\/can.2015.0012","journal-title":"Cannabis Cannabinoid Res"},{"key":"5_CR165","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fvets.2020.00051","volume":"7","author":"D Vaughn","year":"2020","unstructured":"Vaughn D, Kulpa J, Paulionis L (2020) Preliminary Investigation of the Safety of Escalating Cannabinoid Doses in Healthy Dogs. Front Vet Sci 7:51. https:\/\/doi.org\/10.3389\/fvets.2020.00051","journal-title":"Front Vet Sci"},{"key":"5_CR166","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2460\/ajvr.82.5.405","volume":"82","author":"DM Vaughn","year":"2021","unstructured":"Vaughn DM, Paulionis LJ, Kulpa JE (2021) Randomized, placebo-controlled, 28-day safety and pharmacokinetics evaluation of repeated oral cannabidiol administration in healthy dogs. Am J Vet Res 82:405\u2013416. https:\/\/doi.org\/10.2460\/ajvr.82.5.405","journal-title":"Am J Vet Res"},{"key":"5_CR167","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1097\/j.pain.0000000000002466","volume":"163","author":"J Vela","year":"2022","unstructured":"Vela J, Dreyer L, Petersen KK, Arendt-Nielsen L et al (2022) Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial. Pain 163:1206\u20131214. https:\/\/doi.org\/10.1097\/j.pain.0000000000002466","journal-title":"Pain"},{"key":"5_CR168","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.1198687","volume":"331","author":"E Vivier","year":"2011","unstructured":"Vivier E, Raulet DH, Moretta A, Caligiuri MA et al (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331:44\u201349. https:\/\/doi.org\/10.1126\/science.1198687","journal-title":"Science"},{"key":"5_CR169","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3389\/fvets.2020.00505","volume":"7","author":"JJ Wakshlag","year":"2020","unstructured":"Wakshlag JJ, Schwark WS, Deabold KA, Talsma BN et al (2020) Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, \u03949-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract. Front Vet Sci 7:505. https:\/\/doi.org\/10.3389\/fvets.2020.00505","journal-title":"Front Vet Sci"},{"key":"5_CR170","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1523\/jneurosci.23-04-01398.2003","volume":"23","author":"L Walter","year":"2003","unstructured":"Walter L, Franklin A, Witting A, Wade C et al (2003) Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci 23:1398\u20131405. https:\/\/doi.org\/10.1523\/jneurosci.23-04-01398.2003","journal-title":"J Neurosci"},{"key":"5_CR171","doi-asserted-by":"publisher","unstructured":"Wang F, Multhoff G (2021) Repurposing cannabidiol as a potential drug candidate for anti-tumor therapies. Biomolecules 11. https:\/\/doi.org\/10.3390\/biom11040582","DOI":"10.3390\/biom11040582"},{"key":"5_CR172","doi-asserted-by":"publisher","first-page":"12064","DOI":"10.1038\/s41598-017-10924-8","volume":"7","author":"Y Wang","year":"2017","unstructured":"Wang Y, Mukhopadhyay P, Cao Z, Wang H et al (2017) Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury. Sci Rep 7:12064. https:\/\/doi.org\/10.1038\/s41598-017-10924-8","journal-title":"Sci Rep"},{"key":"5_CR173","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/acupmed-2017-011506","volume":"37","author":"Z Wang","year":"2019","unstructured":"Wang Z, Lu M, Ren J, Wu X et al (2019) Electroacupuncture inhibits mast cell degranulation via cannabinoid CB2 receptors in a rat model of allergic contact dermatitis. Acupunct Med 37:348\u2013355. https:\/\/doi.org\/10.1136\/acupmed-2017-011506","journal-title":"Acupunct Med"},{"key":"5_CR174","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.895368","volume":"9","author":"T Wang","year":"2022","unstructured":"Wang T, Zakharov A, Gomez B, Lyubimov A et al (2022) Serum Cannabinoid 24 h and 1 Week Steady State Pharmacokinetic Assessment in Cats Using a CBD\/CBDA Rich Hemp Paste. Front Vet Sci 9:895368. https:\/\/doi.org\/10.3389\/fvets.2022.895368","journal-title":"Front Vet Sci"},{"key":"5_CR175","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molimm.2024.07.008","volume":"174","author":"F Wang","year":"2024","unstructured":"Wang F, Bashiri Dezfouli A, Multhoff G (2024) The immunomodulatory effects of cannabidiol on Hsp70-activated NK cells and tumor target cells. Mol Immunol 174:1\u201310. https:\/\/doi.org\/10.1016\/j.molimm.2024.07.008","journal-title":"Mol Immunol"},{"key":"5_CR176","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1213\/ANE.0b013e3182283486","volume":"113","author":"SJ Ward","year":"2011","unstructured":"Ward SJ, Ramirez MD, Neelakantan H, Walker EA (2011) Cannabidiol prevents the development of cold and mechanical allodynia in paclitaxel-treated female C57Bl6 mice. Anesth Analg 113:947\u2013950. https:\/\/doi.org\/10.1213\/ANE.0b013e3182283486","journal-title":"Anesth Analg"},{"key":"5_CR177","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1248\/bpb.19.1109","volume":"19","author":"K Watanabe","year":"1996","unstructured":"Watanabe K, Kayano Y, Matsunaga T, Yamamoto I et al (1996) Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids. Biol Pharm Bull 19:1109\u20131111. https:\/\/doi.org\/10.1248\/bpb.19.1109","journal-title":"Biol Pharm Bull"},{"key":"5_CR178","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/08916930500356674","volume":"39","author":"L Weiss","year":"2006","unstructured":"Weiss L, Zeira M, Reich S, Har-Noy M et al (2006) Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity 39:143\u2013151. https:\/\/doi.org\/10.1080\/08916930500356674","journal-title":"Autoimmunity"},{"key":"5_CR179","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.neuropharm.2007.06.029","volume":"54","author":"L Weiss","year":"2008","unstructured":"Weiss L, Zeira M, Reich S, Slavin S et al (2008) Cannabidiol arrests onset of autoimmune diabetes in NOD mice. Neuropharmacology 54:244\u2013249. https:\/\/doi.org\/10.1016\/j.neuropharm.2007.06.029","journal-title":"Neuropharmacology"},{"key":"5_CR180","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jdermsci.2006.10.009","volume":"45","author":"JD Wilkinson","year":"2007","unstructured":"Wilkinson JD, Williamson EM (2007) Cannabinoids inhibit human keratinocyte proliferation through a non-CB1\/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis. J Dermatol Sci 45:87\u201392. https:\/\/doi.org\/10.1016\/j.jdermsci.2006.10.009","journal-title":"J Dermatol Sci"},{"key":"5_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.jevs.2021.103842","volume":"110","author":"MR Williams","year":"2022","unstructured":"Williams MR, Holbrook TC, Maxwell L, Croft CH et al (2022) Pharmacokinetic evaluation of a cannabidiol supplement in horses. J Equine Vet 110:103842. https:\/\/doi.org\/10.1016\/j.jevs.2021.103842","journal-title":"J Equine Vet"},{"key":"5_CR182","doi-asserted-by":"publisher","unstructured":"W\u00f3jcik P, Garley M, Wro\u0144ski A, Jab\u0142o\u0144ska E et al (2020) Cannabidiol modifies the formation of NETs in neutrophils of psoriatic patients. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/ijms21186795","DOI":"10.3390\/ijms21186795"},{"key":"5_CR183","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.gastro.2005.05.026","volume":"129","author":"K Wright","year":"2005","unstructured":"Wright K, Rooney N, Feeney M, Tate J et al (2005) Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology 129:437\u2013453. https:\/\/doi.org\/10.1016\/j.gastro.2005.05.026","journal-title":"Gastroenterology"},{"key":"5_CR184","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1093\/rheumatology\/keq045","volume":"49","author":"HL Wright","year":"2010","unstructured":"Wright HL, Moots RJ, Bucknall RC, Edwards SW (2010) Neutrophil function in inflammation and inflammatory diseases. Rheumatology 49:1618\u20131631","journal-title":"Rheumatology"},{"key":"5_CR185","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/glia.22345","volume":"60","author":"HY Wu","year":"2012","unstructured":"Wu HY, Goble K, Mecha M, Wang CC et al (2012) Cannabidiol-induced apoptosis in murine microglial cells through lipid raft. Glia 60:1182\u20131190. https:\/\/doi.org\/10.1002\/glia.22345","journal-title":"Glia"},{"key":"5_CR186","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature12034","volume":"496","author":"TA Wynn","year":"2013","unstructured":"Wynn TA, Chawla A, Pollard JW (2013) Macrophage biology in development, homeostasis and disease. Nature 496:445\u2013455. https:\/\/doi.org\/10.1038\/nature12034","journal-title":"Nature"},{"key":"5_CR187","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188905","volume":"1878","author":"C Yan","year":"2023","unstructured":"Yan C, Li Y, Liu H, Chen D et al (2023) Antitumor mechanism of cannabidiol hidden behind cancer hallmarks. Biochim Biophys Acta Rev Cancer 1878:188905. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188905","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"5_CR188","doi-asserted-by":"publisher","unstructured":"Yekhtin Z, Khuja I, Meiri D, Or R et al (2022) Differential effects of D9 tetrahydrocannabinol (THC)- and cannabidiol (CBD)-based cannabinoid treatments on macrophage immune function In Vitro and on gastrointestinal inflammation in a murine model. Biomedicines 10. https:\/\/doi.org\/10.3390\/biomedicines10081793","DOI":"10.3390\/biomedicines10081793"},{"key":"5_CR189","first-page":"3448","volume":"8","author":"A Zgair","year":"2016","unstructured":"Zgair A, Wong JC, Lee JB, Mistry J et al (2016) Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines. Am J Transl Res 8:3448\u20133459","journal-title":"Am J Transl Res"},{"key":"5_CR190","doi-asserted-by":"publisher","first-page":"14542","DOI":"10.1038\/s41598-017-15026-z","volume":"7","author":"A Zgair","year":"2017","unstructured":"Zgair A, Lee JB, Wong JCM, Taha DA et al (2017) Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation. Sci Rep 7:14542. https:\/\/doi.org\/10.1038\/s41598-017-15026-z","journal-title":"Sci Rep"},{"key":"5_CR191","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1016\/j.cgh.2023.07.008","volume":"21","author":"T Zheng","year":"2023","unstructured":"Zheng T, BouSaba J, Taylor A, Dilmaghani S et al (2023) A Randomized, Controlled Trial of Efficacy and Safety of Cannabidiol in Idiopathic and Diabetic Gastroparesis. Clin Gastroenterol Hepatol 21:3405-3414.e3404. https:\/\/doi.org\/10.1016\/j.cgh.2023.07.008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5_CR192","doi-asserted-by":"publisher","first-page":"1147991","DOI":"10.3389\/fimmu.2023.1147991","volume":"14","author":"A Zieli\u0144ska","year":"2023","unstructured":"Zieli\u0144ska A, Eder P, Karczewski J, Szalata M et al (2023) Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review. Front Immunol 14:1147991. https:\/\/doi.org\/10.3389\/fimmu.2023.1147991","journal-title":"Front Immunol"},{"key":"5_CR193","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cytogfr.2018.08.001","volume":"42","author":"B Zitti","year":"2018","unstructured":"Zitti B, Bryceson YT (2018) Natural killer cells in inflammation and autoimmunity. Cytokine Growth Factor Rev 42:37\u201346. https:\/\/doi.org\/10.1016\/j.cytogfr.2018.08.001","journal-title":"Cytokine Growth Factor Rev"},{"key":"5_CR194","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1096\/fj.08-118323","volume":"23","author":"RB Zurier","year":"2009","unstructured":"Zurier RB, Sun YP, George KL, Stebulis JA et al (2009) Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4. Faseb j 23:1503\u20131509. https:\/\/doi.org\/10.1096\/fj.08-118323","journal-title":"Faseb j"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44446-025-00005-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44446-025-00005-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44446-025-00005-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:48:21Z","timestamp":1757173701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44446-025-00005-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":194,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["5"],"URL":"https:\/\/doi.org\/10.1007\/s44446-025-00005-7","relation":{},"ISSN":["1319-0164","2213-7475"],"issn-type":[{"value":"1319-0164","type":"print"},{"value":"2213-7475","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"26 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}